The trajectory of Sildenafil presents a intricate picture for shareholders. While the initial launch generated massive returns, the expiration of its intellectual property protection opened the floodgates to generic https://gogogobookmarks.com/story21667190/sildenafil-and-the-pharmaceutical-industry-a-precarious-opportunity